Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Aidoc Raises $150 Million in Series E

Aidoc, a New York–based clinical AI company, has raised $150 million in a Series E funding round, bringing its total funding to over $500 million.

Ben Murray profile image
by Ben Murray
Aidoc Raises $150 Million in Series E

Aidoc, a New York–based clinical AI company, has raised $150 million in a Series E funding round, bringing its total funding to over $500 million. 

Investors 

The round was led by Growth Equity at Goldman Sachs Alternatives, with participation from General Catalyst, SoftBank Investment Advisors, and NVentures. 

Growth Equity at Goldman Sachs Alternatives is part of Goldman Sachs Alternatives, a global investor in alternative assets managing over $625 billion in assets. The firm invests across private equity, private credit, real estate, infrastructure, sustainability, and hedge funds. Since 2003, Growth Equity at Goldman Sachs Alternatives has invested more than $13 billion in growth-stage, technology-driven businesses across multiple industries. As of March 31, 2026, Goldman Sachs had approximately $3.7 trillion in assets under supervision globally.a 

Aidoc Use of Funds 

The company will use the funding to advance its clinical foundation model, CARE™, expand into additional medical indications, and scale the global deployment of its enterprise AI platform. 

About Aidoc 

Led by CEO Elad Walach, Aidoc is a clinical AI company focused on helping physicians make earlier, safer diagnoses by transforming raw patient data into actionable insights. The company is powered by its proprietary CARE™ foundation model and an enterprise AI platform, Aidoc aiOS™, embedding AI directly into clinical workflows. It enables health systems to deploy, manage, and scale multiple FDA-cleared solutions through a centralized operating layer. Headquartered in New York, Aidoc's technology is deployed across nearly 2,000 hospitals worldwide and processes tens of millions of patient cases annually. 

Funding Details 

Company: Aidoc 

Raised: $150.0M 

Round: Series E 

Funding Date: April 2026 

Lead Investor: Growth Equity at Goldman Sachs Alternatives 

Additional Investors: General Catalyst, SoftBank Investment Advisors, NVentures 

Company Website: https://www.aidoc.com/  

Software Category: Healthcare AI / Clinical AI Platform 

Source: https://www.prnewswire.com/news-releases/aidoc-raises-150-million-series-e-led-by-goldman-sachs-to-scale-clinical-ai-for-earlier-safer-diagnoses-302757181.html 

Ben Murray profile image
by Ben Murray

Subscribe to New Posts

Learn what companies and software categories are raising!

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Read More